BeOne Medicines
Tiffany Montellano, Ph.D. has extensive work experience in the medical and scientific field. Tiffany is currently the Scientific Director of Global Medical Affairs at BeiGene, a position they have held since August 2021. Prior to this role, they worked as the Director of Medical Affairs at Kura Oncology, Inc. for a year from June 2020 to August 2021.
Before joining Kura Oncology, Inc., Tiffany had a series of roles at Tocagen Inc. starting from 2016. Tiffany served as the Director of Medical Communications and Medical Affairs from February 2019 to March 2020. Prior to that, they were the Director of Medical Science Liaison from February 2018 to February 2019 and a Medical Science Liaison from January 2016 to February 2018.
Tiffany's earlier experience includes working as the Clinical Project Manager Lead at Epic Sciences from December 2014 to January 2016. Prior to that, they worked as a Research Scientist II from April 2013 to December 2014 and as a Research Scientist I from August 2010 to April 2013 at Tocagen Inc.
Tiffany Montellano, Ph.D., obtained their Bachelor of Science degree in Biology from the University of California, Irvine in 1999. Tiffany then went on to pursue their Ph.D. in Immunology/Molecular Biology at UCLA, completing their studies in 2003.
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.